Innovative Implementation, Ethical Challenges, and Future Prospects of Artificial Intelligence in Pharmaceuticals
S. Reshma, Jigar Rupani, M. Lalitha, K. Gowri, Mani Sambathkumar, M. Suresh · 2025
Incorporation of pharmaceutical industry and artificial intelligence (AI) is revolutionizing patient care, drug development, and discovery. Drug interactions have been predicted using machine learning techniques, optimal molecular structures have been designed, and clinical trial lengths have been reduced. Ethical problems including violations of data privacy, biassed algorithms, and unequal access to AI-informed treatments have been highlighted in the face of these technologies Reacting to these problems, regulatory models have been debated and passed. It is well known that artificial intelligence can drive therapeutic developments and customize medicine. One expects continuous innovations in artificial intelligence technologies to change the pharmaceutical industry. Ethical standards must be reinforced and openness kept if artificial intelligence is to be fully embraced. Innovation must guide newly developing projects.